bpi pharmacy tirzepatide compounding FDA says compounding pharmacies can keep making weight-loss med tirzepatide, for now May 18, 2026: FDA warns

We look forward to seeing your accomplishments and success within this strategic partnership

EllieMD states that Brand Partner commissions come from company revenue, not customer markups

"Starter" drug for new individuals Some patients may experiment with low-cost semaglutide to test the waters before moving on to newer, more effective (in terms of initial weight loss) therapies such as tirzepatide or future orals like Lillys orforglipron

PMID: 41791543 Int J Biol Macromol S100A4 regulates ferroptosis to suppress cell proliferation via the SLC7A11-GSH axis but facilitates Brucella infection in RAW264.7 macrophages

As the public may recall, Hims & Hers began selling various Eli Lilly drugs on their platform last monthboth branded forms of tirzepatideincluding Zepbound, a GLP-1 receptor agonist approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes